1![www.medscape.com/viewarticle/864011_print www.medscape.com www.medscape.com/viewarticle/864011_print www.medscape.com](https://www.pdfsearch.io/img/7a6e69525d0214a333bd4703c760e221.jpg) | Add to Reading ListSource URL: digestivehealthfoundation.orgLanguage: English - Date: 2016-08-09 08:21:07
|
---|
2![Ixekizumab for moderate to severe chronic plaque psoriasis Ixekizumab for moderate to severe chronic plaque psoriasis](https://www.pdfsearch.io/img/281a38a0dad8b5e44290b0e175dcfb86.jpg) | Add to Reading ListSource URL: www.hsc.nihr.ac.ukLanguage: English |
---|
3![Pharmacology / Monoclonal antibodies / Centocor / Health / Ustekinumab / Psoriatic nails / Etanercept / Psoriatic arthritis / Biologic / Immunosuppressants / Psoriasis / Medicine Pharmacology / Monoclonal antibodies / Centocor / Health / Ustekinumab / Psoriatic nails / Etanercept / Psoriatic arthritis / Biologic / Immunosuppressants / Psoriasis / Medicine](/pdf-icon.png) | Add to Reading ListSource URL: preview.thenewsmarket.comLanguage: English - Date: 2015-05-29 06:55:23
|
---|
4![STELARATM (ustekinumab) STN: BLHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA™ safely and effectively. See full prescribing information for STE STELARATM (ustekinumab) STN: BLHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA™ safely and effectively. See full prescribing information for STE](https://www.pdfsearch.io/img/0e12177f7562fe0d5f2d6e31dec34304.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-01-29 14:43:31
|
---|
5![Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement](https://www.pdfsearch.io/img/1989d7715e7f5d5b16a1d29fd4fb9c3d.jpg) | Add to Reading ListSource URL: www.janssen.comLanguage: English - Date: 2015-05-04 18:18:43
|
---|
6![Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca](https://www.pdfsearch.io/img/9219d80c858d4cabdde079cff5500045.jpg) | Add to Reading ListSource URL: www.novartis.caLanguage: English - Date: 2015-05-13 10:22:14
|
---|
7![Pharmaceutical sciences / Immunosuppressants / Monoclonal antibodies / Ustekinumab / Infliximab / Golimumab / Clinical trial / Biologic / Psoriasis / Centocor / Pharmacology / Medicine Pharmaceutical sciences / Immunosuppressants / Monoclonal antibodies / Ustekinumab / Infliximab / Golimumab / Clinical trial / Biologic / Psoriasis / Centocor / Pharmacology / Medicine](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-04-22 23:39:46
|
---|
8![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral](https://www.pdfsearch.io/img/f1ba17668057dbaf836f738d5f421225.jpg) | Add to Reading ListSource URL: assets1.celgene.comLanguage: English - Date: 2015-02-12 15:53:43
|
---|
9![](https://www.pdfsearch.io/img/c36faa07dde84c16bf1c37c5d38ab910.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-04-22 23:39:46
|
---|
10![Janssen Pharmaceutical Companies US Post-Marketing - Q4 Jan 2015_012915.indd Janssen Pharmaceutical Companies US Post-Marketing - Q4 Jan 2015_012915.indd](https://www.pdfsearch.io/img/03beea4c21e9e5db246c1142ffcef19d.jpg) | Add to Reading ListSource URL: www.janssen.comLanguage: English - Date: 2015-05-04 18:18:43
|
---|